Shares of Novo Nordisk slipped in Monday morning trading after the company announced results of its latest weight-loss drug trial. Novo's results from its Redefine 2 late-stage trial of ...

Novo Nordisk shares fell after the pharmaceutical giant released fresh trial results for its CagriSema developmental weight-loss drug. The Danish company said CagriSema helped obese or overweight ...

cleared Mineralys Therapeutics’ Investigational New Drug (IND) Application for a Phase 2 trial of lorundrostat for moderate-to-severe obstructive sleep apnea (OSA) and hypertension. The company ...

Using data from a recent study, published in a report titled "Oncology Clinical Trials: Drug Development Resources and Case Studies", this article will take a look at resource benchmarks for 29 ...

even though the drug only achieved its primary objective in one of three phase 3 trials. The good news for the company was that tolebrutinib was able to achieve a statistically significant ...

A POWERFUL synthetic drug known as monkey dust has been linked to “multiple overdoses” among inmates in Scots prisons, we can reveal.Lags have bee Jump directly to the content Scottish Sun ...

Novo Nordisk stock tumbled Monday morning after disappointing trial results for its CagriSema weight-loss drug. Shares in rival Eli Lilly also sold off. Find out more: New trial data showed the ...

Alumis' psoriasis drug eliminated red, itchy patches for nearly a third of patients, and their response has yet to hit a plateau. Long-term clinical trial data for an experimental psoriasis drug ...

District Court of Guam Chief Judge Frances Tydingco-Gatewood vacated the March 18 trial date in a massive drug case against a trio of brothers and their alleged drug supplier. During what was to ...